Mass General/North Shore Cancer Center is a clinical research site located in Danvers, Massachusetts, United States 01923.
Crixeo Clinical Trials Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.
Mass General/North Shore Cancer Center has participated in 26 clinical trials with 12 currently active.
Therapeutic areas: Prostate Cancer, Estrogen Receptor Positive Breast Cancer, Progesterone Receptor Positive Tumor.
Sponsors: Radiation Therapy Oncology Group, ETOP IBCSG Partners Foundation, Alliance for Clinical Trials in Oncology.
Trust Score: 82/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Mass General/North Shore Cancer Center has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Mass General/North Shore Cancer Center has 26 clinical trials on record, with 12 currently active. Their work covers Prostate Cancer, Estrogen Receptor Positive Breast Cancer, Progesterone Receptor Positive Tumor.
Mass General/North Shore Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.